The α1, α2, α3, and γ2 subunits of GABAA receptors show characteristic spatial and temporal expression patterns in rhombencephalic structures during normal human brain development. 2016

Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
Institute of Neurology, Neurodegeneration Research Group, Medical University of Vienna, Vienna, Austria.

γ-Aminobutyric acid (GABA) is the most abundant inhibitory neurotransmitter in adult mammalian brain, mediating its actions chiefly via a pentameric chloride ion channel, the GABAA receptor. Nineteen different subunits (α1-6, β1-3, γ1-3, δ, ε, π, θ, ρ1-3) can give rise to multiple receptor subtypes that are the site of action of many clinically important drugs. In the developing brain, however, GABAA receptors mediate excitatory actions due to an increased chloride concentration within neurons and seem to control cell proliferation, migration, differentiation, synapse maturation, and cell death. Little is known about the distribution of single subunits in the human brain. Here we describe developmental changes in the immunohistochemical distribution of four subunits (α1, α2, α3, and γ2) in the human rhombencephalon. The γ2 was the most abundant subunit in all rhombencephalic structures during development and in adults, whereas α subunits showed a structure- and age-characteristic distribution. The α1 was expressed prenatally in the molecular and Purkinje cell layer, but only postnatally in the granule cell layer and the dentate nucleus. Expression was completely absent in the inferior olivary nucleus. The α2 gradually increased during development, showing some layer specificity in the cerebellar cortex. The α3-immunoreactivity in the cerebellar cortex was relatively weak, but it was abundantly observed in different cell populations in the subcortical cerebellar structures. Structure- and age-characteristic colocalization between subunits during development suggests differences in GABAA receptor composition. Interestingly, subunit expression in several instances differed between human and rodent brain, underlining the importance of immunohistochemical studies in humans.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
July 2017, Journal of chemical neuroanatomy,
Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
January 2017, Developmental neuroscience,
Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
December 1992, Journal of molecular neuroscience : MN,
Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
November 2013, Brain research,
Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
June 2022, The International journal of neuroscience,
Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
January 2011, Developmental neuroscience,
Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
July 1991, FEBS letters,
Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
March 2008, Physiologia plantarum,
Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
October 2013, The Journal of pharmacology and experimental therapeutics,
Tamara Stojanovic, and Ivan Capo, and Eleonora Aronica, and Homa Adle-Biassette, and Harald Höger, and Werner Sieghart, and Gabor G Kovacs, and Ivan Milenkovic
April 1986, The EMBO journal,
Copied contents to your clipboard!